MACSF's venture capital investment focus is primarily on the healthcare and technology sectors, with a strong emphasis on e-health start-ups. Their strategy involves supporting innovations that benefit health professionals, often through early-stage investments like Series A rounds.
57% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-a (43% of deals). Average disclosed round size is $22.6M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRDS | Series A | $14M | Sep 2025 |
 Gleamer | Series B | $29.5M | Jun 2023 |
 Resilience | Series A | $45M | Jan 2022 |
| WWandercraft | Series C | $45M | Jan 2022 |
 Savana | Series B | $15M | Oct 2020 |
 Synapse Medicine | Series A | $8M | Jul 2020 |
| WWellium | Seed | $2M | Mar 2020 |
Top Co-Investors
XAnge2 shared
Bpifrance2 shared
Cathay Innovation2 shared
Seaya2 shared
Supernova Invest1 shared
Elaia1 shared
Singular1 shared
Exor Seeds1 shared
Picus Capita1 shared
Quadrant Capital1 shared
BNP Paribas1 shared
BPI1 shared
Last updated: 21 April 2026